Literature DB >> 10714984

Reinvestigation of the proteolytic activity of neocarzinostatin.

B Heyd1, G Lerat, E Adjadj, P Minard, M Desmadril.   

Abstract

Neocarzinostatin (NCS) is the most studied member of a family of chromoproteins secreted by a range of actinomycetes species. It has been proposed that in addition to their antitumoral activity related to the bound chromophores, this group of related proteins could be a secreted proteases superfamily. With the aim of dissecting the molecular basis of the proteolytic activity of NCS, an expression system allowing efficient expression of apo-NCS in Escherichia coli was constructed. The recombinant protein was properly folded and functional. Its histone-specific proteolytic activity was similar to the activity described for the natural protein. Further analyses unambiguously demonstrated that the proteolytic activity could be physically separated from NCS. This activity is therefore due not to NCS itself but to minor contaminating proteases, the nature of which differed in the recombinant and natural NCS preparations. The histone degradation test commonly used to monitor proteolytic activity is extremely sensitive and may easily generate false-positive results. These results strongly suggest that the possible proteolytic activity of the proteins of this family should be critically reconsidered.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10714984      PMCID: PMC101862          DOI: 10.1128/JB.182.7.1812-1818.2000

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  22 in total

1.  Effects of neocarzinostatin on mammalian nuclei: release of nucleosomes.

Authors:  M T Kuo; T S Samy
Journal:  Biochim Biophys Acta       Date:  1978-03-29

2.  Isolation of a homogeneous lysine-rich histone from calf thymus.

Authors:  E de NOOIJ; H G WESTENBRINK
Journal:  Biochim Biophys Acta       Date:  1962-08-27

3.  The proteolytic specificity of the natural enediyne-containing chromoproteins is unique to each chromoprotein.

Authors:  N Zein; P Reiss; M Bernatowicz; M Bolgar
Journal:  Chem Biol       Date:  1995-07

4.  On the role of heme in the formation of the structure of cytochrome c.

Authors:  W R Fisher; H Taniuchi; C B Anfinsen
Journal:  J Biol Chem       Date:  1973-05-10       Impact factor: 5.157

5.  Pre-neocarzinostatin, a specific antagonist of neocarzinostatin.

Authors:  M Kikuchi; M Shoji; N Ishida
Journal:  J Antibiot (Tokyo)       Date:  1974-10       Impact factor: 2.649

6.  Action of neocarzinostatin on cell nuclei: release of specific chromatin.

Authors:  T Hatayama; M Yukioka
Journal:  Biochem Biophys Res Commun       Date:  1982-02-11       Impact factor: 3.575

7.  Maduropeptin: an antitumor chromoprotein with selective protease activity and DNA cleaving properties.

Authors:  N Zein; W Solomon; K L Colson; D R Schroeder
Journal:  Biochemistry       Date:  1995-09-12       Impact factor: 3.162

8.  Roles of chromophore and apo-protein in neocarzinostatin action.

Authors:  L S Kappen; M A Napier; I H Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Effects of neocarzinostatin on chromatin in HeLa S3 nuclei.

Authors:  T A Beerman; G Mueller; H Grimmond
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

10.  In vitro inhibition of human leukemic cells (CCRF-CEM) by agarose-immobilized neocarzinostatin.

Authors:  H Lazarus; V Raso; T S Samy
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

View more
  9 in total

1.  Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.

Authors:  N Izadi-Pruneyre; Y Blouquit; J Perez; P Minard; M Desmadril; J Mispelter
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

2.  Dynamic transition associated with the thermal denaturation of a small Beta protein.

Authors:  Daniela Russo; Javier Pérez; Jean-Marc Zanotti; Michel Desmadril; Dominique Durand
Journal:  Biophys J       Date:  2002-11       Impact factor: 4.033

3.  Cold instability of aponeocarzinostatin and its stabilization by labile chromophore.

Authors:  Kandaswamy Jayachithra; Thallampuranam Krishnaswamy Suresh Kumar; Ta-Jung Lu; Chin Yu; Der-Hang Chin
Journal:  Biophys J       Date:  2005-04-08       Impact factor: 4.033

4.  Characterization of the maduropeptin biosynthetic gene cluster from Actinomadura madurae ATCC 39144 supporting a unifying paradigm for enediyne biosynthesis.

Authors:  Steven G Van Lanen; Tae-Jin Oh; Wen Liu; Evelyn Wendt-Pienkowski; Ben Shen
Journal:  J Am Chem Soc       Date:  2007-10-06       Impact factor: 15.419

5.  Is association of labile enediyne chromophore a mutually assured protection for carrier protein?

Authors:  Jayachithra Kandaswamy; Parameswaran Hariharan; Thallapuranam Krishnaswamy Suresh Kumar; Chin Yu; Ta-Jung Lu; Der-Hang Chin
Journal:  Anal Biochem       Date:  2008-06-14       Impact factor: 3.365

6.  Affinity transfer by CDR grafting on a nonimmunoglobulin scaffold.

Authors:  Magali Nicaise; Marielle Valerio-Lepiniec; Philippe Minard; Michel Desmadril
Journal:  Protein Sci       Date:  2004-05-28       Impact factor: 6.725

7.  Selection of specific protein binders for pre-defined targets from an optimized library of artificial helicoidal repeat proteins (alphaRep).

Authors:  Asma Guellouz; Marie Valerio-Lepiniec; Agathe Urvoas; Anne Chevrel; Marc Graille; Zaineb Fourati-Kammoun; Michel Desmadril; Herman van Tilbeurgh; Philippe Minard
Journal:  PLoS One       Date:  2013-08-27       Impact factor: 3.240

8.  A superior drug carrier--aponeocarzinostatin in partially unfolded state fully protects the labile antitumor enediyne.

Authors:  Aranganathan Shanmuganathan; Thallapuranam Krishnaswamy Suresh Kumar; Chiy-Mey Huang; Chin Yu; Der-Hang Chin
Journal:  J Biomed Sci       Date:  2009-05-23       Impact factor: 8.410

9.  Canonical non-homologous end joining in mitosis induces genome instability and is suppressed by M-phase-specific phosphorylation of XRCC4.

Authors:  Masahiro Terasawa; Akira Shinohara; Miki Shinohara
Journal:  PLoS Genet       Date:  2014-08-28       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.